
Cerebrolysin
Neuropeptide mixture studied for brain-cell protection, communication, and recovery.
For Research Use Only
Sold strictly for laboratory research. Not for human or veterinary use, ingestion, or clinical/diagnostic application.
The lower price is applied automatically once your cart holds 5 or more of this vial.
About this peptide
Cerebrolysin is a purified mixture of small peptides and amino acids derived from porcine brain tissue. Researchers use it to study how brain cells are protected, communicate, and form new connections. Studies also examine its possible role in recovery after neurological injury or age-related decline.
Why researchers reach for Cerebrolysin
Neurotrophic mimicry
Referenced across BDNF/NGF-like activity assays.
Synaptic plasticity
Preclinical data in LTP and dendritic-branching models.
Neuroprotection
Studied in ischemic and traumatic brain injury paradigms.
Key features
- Standardized porcine neuropeptide fraction
- Batch-verified composition
- Endotoxin controlled
- Cold-chain dispatch
How it works
Growth factor mimicry
Peptide fragments engage neurotrophin-like signaling.
Amyloid handling
Modulates APP processing and Aβ clearance markers in vitro.
Metabolic support
Adjusts glucose utilization in neuronal cultures.
Research dosage guidelines
Reference ranges only — reproduced from published preclinical literature. Not a recommendation for human use.
| Range | Reported dose | Note |
|---|---|---|
| Typical reconstitution | 2 mL bacteriostatic water | Yields 30 mg/mL |
| Reported research range | 5–30 mg/day | Reference only |
Tracking this compound? Registered researchers can log active Cerebrolysin protocols in their private Research Log.
Timing in research protocols
Once daily by infusion for 10 consecutive days.
- Large randomised trials including CASTA and NCT00868283 used 30 mL intravenously once daily for 10 consecutive days.
- In the stroke trials, the course was initiated within 12 hours of onset, with follow-up at 90 days.
- Daytime infusion reflects clinical logistics rather than any demonstrated chronotherapeutic effect.
- The studied pattern is a short intensive 10-day course, not chronic use.
Drawn from published research protocols and pharmacology literature. Reference information for laboratory research only — not an instruction or guidance for use.
Technical specifications
- Scientific name
- Peptide fraction of porcine brain protein (neuropeptide preparation)
- Source
- Purified porcine brain fraction
- Composition
- ~25% low-MW peptides + free amino acids
- Purity
- Standardized batch-to-batch
- Form
- Solution / lyophilized
- Vial size
- 60 mg
- Storage (lyophilised vial)
- Cool, dry and protected from light
- Storage (after reconstitution)
- 2–8°C
Published research
Peer-reviewed literature on Cerebrolysin. Links open in a new tab.
Research use notice
Sold for in vitro laboratory research only. Not for human or veterinary use, diagnosis, or therapy.
